Ventricular premature beats
Conditions
Interventions
Test group:Qidong Yixin Granules Usage: 1 bag each time 3 times a day. Combined metoprolol succinate sustained-release tablets (Betaloc). 47.5mg each time once a day.
control group:Metoprolol Succinate Extended Release Tablets (Betaloc). 47.5mg each time once a day.
Sponsors
Hangzhou Zhongmei Huadong Pharmaceutical Co. Ltd
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Participants must meet all of the following inclusion criteria: (1) The diagnosis of ventricular premature beats is based on a 12 lead electrocardiogram and the 24-hour dynamic electrocardiogram shows that the number of premature beats is greater than 2000 and less than 20000; (2) The traditional Chinese medicine syndrome differentiation is qi yin deficiency syndrome; (3) Age between 18 and 70 years old (including 18 and 70 years old) gender is not limited; (4) Heart rate = 60bpm; Voluntarily participate in this clinical trial and sign an informed consent form.
Exclusion criteria
Exclusion criteria: Any of the following cannot be included in the group: (1) Merge malignant or fatal arrhythmias; Combination of grade II-II-II atrioventricular block or structural heart disease; (2) Patients must regularly take medications such as metoprolol succinate sustained-release tablets for the treatment of ventricular premature beats; (3) Liver function ALT and AST exceed the upper limit of normal reference values by 1.5 times or Scr exceeds the upper limit of normal reference values; (4) Combining severe cardiovascular lung liver kidney endocrine or central nervous system diseases (patients with underlying heart disease such as coronary heart disease chronic heart failure etc. can be included in this study); (5) Known to be allergic or ineffective to the investigational drug or its components; (6) Pregnant or lactating women women of childbearing age who cannot take contraceptive measures during the trial period; (7) Participated in clinical trials of other drugs within the past month; The researchers believe that it is not suitable to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall efficiency; | — |
Secondary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine Symptom Score; | — |
Countries
China
Contacts
Public ContactXiaohu Chen
Jiangsu Province Hospital of TCM
Outcome results
None listed